Generic Cancidas Availability
Last updated on Jun 11, 2025.
Cancidas is a brand name of caspofungin, approved by the FDA in the following formulation(s):
CANCIDAS (caspofungin acetate - powder;intravenous)
-
Manufacturer: MERCK
Approval date: January 26, 2001
Strength(s): 50MG/VIAL (discontinued) [RLD], 70MG/VIAL (discontinued) [RLD]
All of the above formulations have been discontinued.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Cancidas. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: Generic Drug FAQ.
More about Cancidas (caspofungin)
- Cancidas consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- Drug class: echinocandins
- Breastfeeding
- En español
Related treatment guides
Related/similar drugs
Augmentin
Augmentin is a prescription antibiotic combining amoxicillin and clavulanate to treat bacterial ...
Cipro
Cipro (ciprofloxacin) is a fluoroquinolone antibiotic used to treat bacterial infections. Learn ...
Botox
Botox is used cosmetically to reduce facial lines and wrinkles and for medical purposes for ...
Zosyn
Zosyn is used to treat bacterial infections such as urinary tract and skin infections and ...
Neulasta
Neulasta is used to stimulate neutrophil growth and reduce infection risk (manifested by febrile ...
Cefepime
Cefepime is used for bacteremia, febrile neutropenia, intraabdominal infection, kidney infections ...
Itraconazole
Itraconazole is used for aspergillosis, aspergilloma, aspergillosis, invasive, blastomycosis ...
Piperacillin/tazobactam
Piperacillin/tazobactam is used for appendectomy, appendicitis, aspiration pneumonia, bacteremia ...
Gentamicin
Gentamicin is used for bacteremia, bacterial endocarditis prevention, bacterial infection, bone ...
Vancomycin
Vancomycin is used to treat infections of the intestines that cause colitis. Learn about side ...
Glossary
| Term | Definition |
|---|---|
| Drug Patent | A drug patent is assigned by the U.S. Patent and Trademark Office and assigns exclusive legal right to the patent holder to protect the proprietary chemical formulation. The patent assigns exclusive legal right to the inventor or patent holder, and may include entities such as the drug brand name, trademark, product dosage form, ingredient formulation, or manufacturing process A patent usually expires 20 years from the date of filing, but can be variable based on many factors, including development of new formulations of the original chemical, and patent infringement litigation. |
| Drug Exclusivity | Exclusivity is the sole marketing rights granted by the FDA to a manufacturer upon the approval of a drug and may run simultaneously with a patent. Exclusivity periods can run from 180 days to seven years depending upon the circumstance of the exclusivity grant. |
| RLD | A Reference Listed Drug (RLD) is an approved drug product to which new generic versions are compared to show that they are bioequivalent. A drug company seeking approval to market a generic equivalent must refer to the Reference Listed Drug in its Abbreviated New Drug Application (ANDA). By designating a single reference listed drug as the standard to which all generic versions must be shown to be bioequivalent, FDA hopes to avoid possible significant variations among generic drugs and their brand name counterpart. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.